Ranolazine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69367-293
  • Package NDC 69367-293-60
  • Application number ANDA211829
  • SPL ID 38a38464-5bd7-40e4-82fc-2fc5fe42cef8
  • SPL set ID b91e88a0-04d0-4d0d-92d8-966b27a48e29
  • UNII A6IEZ5M406
  • RxCUI 616749
  • RxCUI 728231

What the source publishes

Labeler
Westminster Pharmaceuticals, LLC
Active ingredients
Ranolazine
Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69367-293_38a38464-5bd7-40e4-82fc-2fc5fe42cef8
{
  "name": "Ranolazine",
  "splId": "38a38464-5bd7-40e4-82fc-2fc5fe42cef8",
  "labels": [
    {
      "setId": "b91e88a0-04d0-4d0d-92d8-966b27a48e29",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b91e88a0-04d0-4d0d-92d8-966b27a48e29",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b91e88a0-04d0-4d0d-92d8-966b27a48e29"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Westminster Pharmaceuticals, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69367-293-60)",
      "package_ndc": "69367-293-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210824"
    }
  ],
  "productId": "69367-293_38a38464-5bd7-40e4-82fc-2fc5fe42cef8",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
  "productNdc": "69367-293",
  "deaSchedule": null,
  "genericName": "Ranolazine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RANOLAZINE",
      "strength": "500 mg/1"
    }
  ],
  "applicationNumber": "ANDA211829",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210824",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175427",
      "N0000190114",
      "N0000185503",
      "N0000182137",
      "N0000187061"
    ],
    "upc": [
      "0369367293600",
      "0369367294607"
    ],
    "unii": [
      "A6IEZ5M406"
    ],
    "rxcui": [
      "616749",
      "728231"
    ],
    "spl_set_id": [
      "b91e88a0-04d0-4d0d-92d8-966b27a48e29"
    ],
    "pharm_class_epc": [
      "Anti-anginal [EPC]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 3A Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Organic Cation Transporter 2 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Westminster Pharmaceuticals, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69367-293_38a38464-5bd7-40e4-82fc-2fc5fe42cef8"